Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy
Differential gene expression during HIV-1 infection analyzed by suppression subtractive hybridization
Factors related to loss of HIV-specific cytotoxic T lymphocyte activity
Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function
Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population
Healthcare use by varied highly active antiretroviral therapy (HAART) strata
Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects
The metabolic effects of lopinavir/ritonavir in HIV-negative men
GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients
HIV and pulmonary tuberculosis
Levels and causes of adult mortality in rural South Africa
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion
Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study*
Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues
Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients
Effect on CD4 T-cell count of replacing protease inhibitors in patients with successful HIV suppression
Hormonal contraception and risk of HIV-1 acquisition
Acceptability and uptake of a package to prevent mother-to-child transmission using rapid HIV testing in Abidjan, Côte d'Ivoire
Demodex folliculitis
Progressive multifocal leukoencephalopathy in an HIV patient with normal CD4 T-cell count and magnetic resonance imaging
Optimizing dosing strategies for the combination of atazanavir plus saquinavir
Lopinavir–ritonavir (Kaletra) and lithiasis
Rifampicin-containing regimens for the treatment of latent tuberculosis infection also prevented diarrheal illnesses in HIV-infected Ugandan adults
Comment on ‘A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy’ by Lalezari et al.